Trial Profile
Clopidogrel Medco Outcomes Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2010
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Esomeprazole; Lansoprazole; Omeprazole; Pantoprazole; Proton pump inhibitors; Rabeprazole
- Indications Angina pectoris; Cardiovascular disorders; Coronary disorders; Death; Embolism and thrombosis; Gastro-oesophageal reflux; Gastrointestinal disorders; Myocardial infarction; Stroke; Transient ischaemic attacks
- Focus Therapeutic Use
- Acronyms CMOS
- 01 Aug 2010 Primary endpoint results published in Pharmacotherapy
- 01 Aug 2010 Elderly added as descriptor, and elderly and adults added as age keywords
- 27 Jul 2010 Results reported in Pharmacotherapy, according to a Medco media release.